Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · IEX Real-Time Price · USD
1.300
-0.050 (-3.70%)
At close: Jul 2, 2024, 4:00 PM
1.290
-0.010 (-0.77%)
After-hours: Jul 2, 2024, 7:51 PM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $217.63 million as of July 2, 2024. Its market cap has decreased by -15.42% in one year.
Market Cap
217.63M
Enterprise Value
126.67M
1-Year Change
-15.42%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $217.63M, a decrease of -90.49%. That is a compound annual growth rate of -53.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 226.00M | -3.46% |
| Dec 29, 2023 | 234.10M | -46.94% |
| Dec 30, 2022 | 441.20M | -63.93% |
| Dec 31, 2021 | 1.22B | -46.56% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AngioDynamics | 229.11M |
| Omeros | 228.88M |
| ESSA Pharma | 227.14M |
| Q32 Bio | 226.66M |
| Skye Bioscience | 226.23M |
| Nektar Therapeutics | 224.50M |
| Inovio Pharmaceuticals | 223.09M |
| Aquestive Therapeutics | 223.04M |